Molecular Classification and Survival Prediction in Human Gliomas Based on Proteome Analysis

The biological features of gliomas, which are characterized by highly heterogeneous biological aggressiveness even in the same histological category, would be precisely described by global gene expression data at the protein level. We investigated whether proteome analysis based on two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry can identify differences in protein expression between high- and low-grade glioma tissues. Proteome profiling patterns were compared in 85 tissue samples: 52 glioblastoma multiforme, 13 anaplastic astrocytomas, 10 atrocytomas, and 10 normal brain tissues. We could completely distinguish the normal brain tissues from glioma tissues by cluster analysis based on the proteome profiling patterns. Proteome-based clustering significantly correlated with the patient survival, and we could identify a biologically distinct subset of astrocytomas with aggressive nature. Discriminant analysis extracted a set of 37 proteins differentially expressed based on histological grading. Among them, many of the proteins that were increased in high-grade gliomas were categorized as signal transduction proteins, including small G-proteins. Immunohistochemical analysis confirmed the expression of identified proteins in glioma tissues. The present study shows that proteome analysis is useful to develop a novel system for the prediction of biological aggressiveness of gliomas. The proteins identified here could be novel biomarkers for survival prediction and rational targets for antiglioma therapy.

[1]  D. Gutmann,et al.  Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. , 2001, Cancer research.

[2]  B. Futcher,et al.  A Sampling of the Yeast Proteome , 1999, Molecular and Cellular Biology.

[3]  C. Siao,et al.  Tissue Plasminogen Activator Mediates Microglial Activation via Its Finger Domain through Annexin II , 2002, The Journal of Neuroscience.

[4]  Morten Østergaard,et al.  Human 2‐D PAGE databases for proteome analysis in health and disease: http ://biobase.dk/cgi‐bin/celis , 1996, FEBS letters.

[5]  W. Houry,et al.  Chaperone-assisted protein folding in the cell cytoplasm. , 2001, Current protein & peptide science.

[6]  O. Kallioniemi,et al.  Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. , 2000, Cancer research.

[7]  D. Gutmann,et al.  Aberrant G protein signaling in nervous system tumors. , 2002, Journal of neurosurgery.

[8]  S. Oliver.  Proteomics: Guilt-by-association goes global , 2000, Nature.

[9]  Richard LeBlanc,et al.  Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes. , 2002, Cancer research.

[10]  David E. Misek,et al.  Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. , 2001, Cancer research.

[11]  T. Poggio,et al.  Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.

[12]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[13]  J. Blendy,et al.  Activating Transcription Factor 1 and CREB Are Important for Cell Survival during Early Mouse Development , 2002, Molecular and Cellular Biology.

[14]  M. Rosenblum,et al.  Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma. , 1992, Cancer research.

[15]  A. Ridley,et al.  Rho: theme and variations , 1996, Current Biology.

[16]  Andreas D. Baxevanis,et al.  A user's guide to the human genome , 2002, Nature Genetics.

[17]  呉 泰次郎.  Theme and variation , 1941 .

[18]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[19]  D. Hochstrasser,et al.  Improved and simplified in‐gel sample application using reswelling of dry immobilized pH gradients , 1997, Electrophoresis.

[20]  W. Reinhold,et al.  Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. , 1993, The Journal of clinical investigation.

[21]  Jacqueline Palmari,et al.  PAI-1 and EGFR expression in adult glioma tumors: toward a molecular prognostic classification. , 2002, International journal of radiation oncology, biology, physics.